Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
0.5643
+0.0328 (6.17%)
At close: Sep 11, 2026, 4:00 PM EDT
0.5775
+0.0132 (2.34%)
After-hours: Sep 11, 2026, 7:53 PM EDT

Traws Pharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-21.579.17-166.52-18.95-18.96-16.16
Depreciation & Amortization
0.150.060.010.020.010.01
Asset Writedown & Restructuring Costs
--117.46---
Stock-Based Compensation
1.910.731.391.31.170.58
Other Operating Activities
0.04-26.5724.44---0.32
Change in Accounts Receivable
-2.13-2.03-1.750.01-00.01
Change in Accounts Payable
3.53-0.610.651.761.1-2.08
Change in Unearned Revenue
--2.79-0.23-0.23-0.23-0.23
Change in Other Net Operating Assets
1.233.86-5.25-1.850.61-1.3
Operating Cash Flow
-16.85-18.19-29.79-17.93-16.29-19.49
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
----0.01--
Cash Acquisitions
---3.65---
Sale (Purchase) of Intangibles
-2.59-2.59----
Investing Cash Flow
-2.59-2.59-3.65-0.01--

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
14.235.6133.98--55.56
Other Financing Activities
-2.85-2.4----
Financing Cash Flow
11.383.233.98--55.56

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.010.05-0.020.01-0.02-0.03
Net Cash Flow
-8.07-17.520.52-17.94-16.3136.05

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-16.85-18.19-29.79-17.95-16.29-19.49
Free Cash Flow Growth
------
Free Cash Flow Margin
--651.79%-13182.30%-7940.71%-7209.74%-8622.57%
Free Cash Flow Per Share
-1.51-2.21-19.19-21.38-19.48-28.94
Levered Free Cash Flow
-13.33-13.9-13.63-11.46-9.38-13.23
Unlevered Free Cash Flow
-13.33-13.9-13.63-11.46-9.38-13.23

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
2.62-1.58-6.57-0.31.48-3.59
SEC Filings: 10-K · 10-Q